1. Home
  2. AMPH vs RPD Comparison

AMPH vs RPD Comparison

Compare AMPH & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$20.18

Market Cap

885.4M

Sector

Health Care

ML Signal

HOLD

Logo Rapid7 Inc.

RPD

Rapid7 Inc.

HOLD

Current Price

$13.78

Market Cap

746.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
RPD
Founded
1996
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
885.4M
746.5M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
AMPH
RPD
Price
$20.18
$13.78
Analyst Decision
Buy
Hold
Analyst Count
8
23
Target Price
$28.38
$15.05
AVG Volume (30 Days)
444.5K
2.6M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.81
0.11
Revenue
$719,887,000.00
$685,083,000.00
Revenue This Year
$6.90
N/A
Revenue Next Year
$4.64
$0.54
P/E Ratio
$24.67
$116.00
Revenue Growth
N/A
N/A
52 Week Low
$16.65
$4.97
52 Week High
$31.26
$21.76

Technical Indicators

Market Signals
Indicator
AMPH
RPD
Relative Strength Index (RSI) 52.27 69.51
Support Level $18.36 $12.73
Resistance Level $20.29 $13.75
Average True Range (ATR) 0.77 0.88
MACD 0.03 0.27
Stochastic Oscillator 32.84 77.94

Price Performance

Historical Comparison
AMPH
RPD

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

Share on Social Networks: